bay-k-8644 and remifentanil

bay-k-8644 has been researched along with remifentanil in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, L; Chen, Z; Gao, X; Li, Z; Lin, C; Liu, T; Qi, F; Tang, H; Wang, L; Wang, ZJ; Zhang, X	1

Other Studies

1 other study(ies) available for bay-k-8644 and remifentanil

Article	Year
Ketamine reduces remifentanil-induced postoperative hyperalgesia mediated by CaMKII-NMDAR in the primary somatosensory cerebral cortex region in mice. Neuropharmacology, 2020, 01-01, Volume: 162 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics; Analgesics, Opioid; Animals; Benzylamines; Blotting, Western; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Fluorescent Antibody Technique; Hyperalgesia; Ketamine; Mice; Pain Threshold; Pain, Postoperative; Postoperative Complications; Protein Kinase Inhibitors; Receptors, N-Methyl-D-Aspartate; Remifentanil; Somatosensory Cortex; Sulfonamides	2020

Article

Year

Ketamine reduces remifentanil-induced postoperative hyperalgesia mediated by CaMKII-NMDAR in the primary somatosensory cerebral cortex region in mice.

Neuropharmacology, 2020, 01-01, Volume: 162

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics; Analgesics, Opioid; Animals; Benzylamines; Blotting, Western; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Fluorescent Antibody Technique; Hyperalgesia; Ketamine; Mice; Pain Threshold; Pain, Postoperative; Postoperative Complications; Protein Kinase Inhibitors; Receptors, N-Methyl-D-Aspartate; Remifentanil; Somatosensory Cortex; Sulfonamides

2020